(19)
(11) EP 4 469 059 A2

(12)

(88) Date of publication A3:
21.09.2023

(43) Date of publication:
04.12.2024 Bulletin 2024/49

(21) Application number: 23743806.4

(22) Date of filing: 23.01.2023
(51) International Patent Classification (IPC): 
A61K 31/575(2006.01)
A61K 31/343(2006.01)
A61P 27/04(2006.01)
 A61K 9/08(2006.01)
A61K 47/10(2017.01)
A61P 27/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 27/02; A61K 31/573; A61K 31/365
 
C-Sets:
  1. A61K 31/365, A61K 2300/00;
  2. A61K 31/573, A61K 2300/00;
(86) International application number:
PCT/US2023/011351
(87) International publication number:
WO 2023/141334 (27.07.2023 Gazette 2023/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 24.01.2022 US 202217582627
08.03.2022 US 202263317770 P
31.08.2022 US 202263402704 P
12.10.2022 US 202263415419 P

(71) Applicant: Surface Ophthalmics, Inc.
Pleasanton, California 94588 (US)

(72) Inventors:
  • HOSSEINI, Kamran
    Pleasanton, California 94588 (US)
  • LINDSTROM, Richard
    Wayzata, Minnesota 55391 (US)

(74) Representative: Roth, Andy Stefan 
Dr. Roth Patentanwaltskanzlei Plange Mühle 5
40221 Düsseldorf
40221 Düsseldorf (DE)

   


(54) PHARMACEUTICAL COMPOSITIONS OF MYCOPHENOLIC ACID AND/OR BETAMETHASONE FOR THE TREATMENT OF OCULAR DISORDERS